Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5225 Mid America Plz
Saint Louis, MO 63129Phone+1 314-747-7222Fax+1 314-286-1021- Is this information wrong?
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1986
- Indiana University School of MedicineResidency, Internal Medicine, 1980 - 1983
- Indiana University School of MedicineInternship, Internal Medicine, 1980 - 1981
- Saint Louis University School of MedicineClass of 1980
Certifications & Licensure
- MO State Medical License 2010 - 2025
- TN State Medical License 1999 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Join now to see all
Clinical Trials
- Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract Start of enrollment: 1997 Jul 15
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium Start of enrollment: 1998 Dec 03
- Combination Chemotherapy in Treating Patients With Bladder Cancer Start of enrollment: 1999 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).Morris MJ, Heller G, Hillman DW, Bobek O, Ryan C, Antonarakis ES, Bryce AH, Hahn O, Beltran H, Armstrong AJ, Schwartz L, Lewis LD, Beumer JH, Langevin B, McGary EC, Me...> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023-03-30
- 15 citationsOrteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain, Shilpa Gupta, Melissa Plets, Primo N Lara, Andrea L Harzstark, Przemyslaw W Twardowski, Channing J Paller, Dylan ...> ;Journal of Clinical Oncology. 2022 Oct 1
- 4 citationsAssociation Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemoth...Benjamin W Fischer-Valuck, Sagar A Patel, Randall J Brenneman, John Christodouleas, Paul Sargos, Eric Kim, Aaron Weiss, Bruce Hershatter, Yuan J Rao, Joel Picus, Bruce...> ;European Urology Oncology. 2022 Apr 1
- Join now to see all
Press Mentions
- Collaboration Between Rheumatologists, Primary Care Reduces Delay in Axial SpA DiagnosisAugust 4th, 2021
- VA Pathologist Created Scoring System That Predicts Aggressiveness of Prostate CancerNovember 5th, 2020
- New Drug May Boost Survival for Advanced Prostate Cancer Patients: Study - US NewsJune 2nd, 2014
- Join now to see all
Committees
- Member, Castration-resistant Prostate Cancer Guidelines Panel, AUA 2015 - 2018
- Chairman, Oncology Drug Advisory Committee of the FDA 2014 - 2018
Professional Memberships
- Fellow
Hospital Affiliations
- Barnes-Jewish HospitalSaint Louis, Missouri
- Siteman Cancer CenterSaint Louis, Missouri
- Christian HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: